Beijing Centergate Technologies (holding) Co., Ltd. (SHE:000931)

China flag China · Delayed Price · Currency is CNY
5.23
+0.06 (1.16%)
At close: Jan 23, 2026
15.96%
Market Cap3.94B
Revenue (ttm)2.48B
Net Income (ttm)51.45M
Shares Out753.13M
EPS (ttm)0.07
PE Ratio76.56
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume15,371,410
Average Volume15,572,064
Open5.18
Previous Close5.17
Day's Range5.15 - 5.29
52-Week Range3.92 - 5.86
Beta0.63
RSI61.06
Earnings DateApr 18, 2026

About SHE:000931

Beijing Centergate Technologies (holding) Co., Ltd. engages in the pharmaceutical industry in China and internationally. The company offers Anemarrhena saponin BII and capsules for vascular dementia treatment; Bifonazole API, an opioid receptor antagonist; Naloxone Hydrochloride injection to relieve acute ethanol poisoning; Naltrexone Hydrochloride tablets to block the pharmacological effects of exogenous opioids; Hydrocodone acetaminophen tablets for the treatment of moderate to severe pain; Ambroxol Hydrochloride injection for acute and chron... [Read more]

Sector Healthcare
Founded 1999
Employees 2,267
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000931
Full Company Profile

Financial Performance

In 2024, SHE:000931's revenue was 2.53 billion, an increase of 11.22% compared to the previous year's 2.28 billion. Earnings were 53.59 million, an increase of 10.33%.

Financial Statements